Notable Labs' mission is to change the way cancer is treated, which starts with putting patients first. The company is developing a personalized treatment service for people with cancer that prioritizes combinations of FDA-approved treatments that can be immediately prescribed by a doctor. Focusing on individual patients and existing treatments, the company is discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance. Using modern data science and robotics, Notable Labs is building a scalable, iterative model with the ultimate aim of turning treatment selection into a data problem.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/07/17 | $10,000,000 | Series A |
BuildersVC | undisclosed |
| 07/16/19 | $40,000,000 | Series B |
B Capital Group LifeForce Capital | undisclosed |
